Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9216)
All Articles published online
|
Publishing Process of This Article
|
Jul 15, 2014 (publication date) through Dec 1, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Recondo GJ, Díaz-Cantón E, de la Vega M, Greco M, Recondo GS, Valsecchi ME. Advances and new perspectives in the treatment of metastatic colon cancer. World J Gastrointest Oncol 2014; 6(7): 211-224 [PMID: 25024813 DOI: 10.4251/wjgo.v6.i7.211] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v6/i7/211.htm |
| Number | Citing Articles |
| 1 |
Jie Zhang, Yao-Tiao Deng, Jie Liu, Lu Gan, Yu Jiang. Role of transforming growth factor-β1 pathway in angiogenesis induced by chronic stress in colorectal cancer. Cancer Biology & Therapy 2024; 25(1) doi: 10.1080/15384047.2024.2366451
|
| 2 |
Rohitas Deshmukh, Mahendra Prajapati, Ranjit K. Harwansh. A review on emerging targeted therapies for the management of metastatic colorectal cancers. Medical Oncology 2023; 40(6) doi: 10.1007/s12032-023-02020-x
|
| 3 |
Takumi Ochiai, Kazuhiko Nishimura, Tomoo Watanabe, Masayuki Kitajima, Akinori Nakatani, Kiichi Nagayasu, Naoki Sakuyama, Tsuyoshi Sato, Kenji Kishine, Yu Abe, Isao Nagaoka. Impact of primary tumor location as a predictive factor in patients suffering from colorectal cancer treated with cytotoxic anticancer agents based on the collagen gel droplet‑embedded drug sensitivity test. Oncology Letters 2018; doi: 10.3892/ol.2018.9805
|
| 4 |
Sang-Eun Park, Kyung-Sook Chung, So-Won Heo, Soo-Yeon Kim, Jeong-Hun Lee, Ahmed H.E. Hassan, Yong Sup Lee, Jae Yeol Lee, Kyung-Tae Lee. Therapeutic role of 2-stearoxyphenethyl phosphocholine targeting microtubule dynamics and Wnt/β-catenin/EMT signaling in human colorectal cancer cells. Life Sciences 2023; 334: 122227 doi: 10.1016/j.lfs.2023.122227
|
| 5 |
Stanislaw R. Burzynski, Tomasz J. Janicki, Gregory S. Burzynski, Sheldon Brookman. Preliminary Findings on the Use of Targeted Therapy in Combination with Sodium Phenylbutyrate in Colorectal Cancer after Failure of Second-Line Therapy—A Potential Strategy for Improved Survival. Journal of Cancer Therapy 2014; 5(13): 1270 doi: 10.4236/jct.2014.513128
|
| 6 |
Yu-Jia Chang, Chien-Yu Huang, Chin-Sheng Hung, Hui-Hsiung Liu, Po-Li Wei. Glucose-regulated protein 78 mediates the therapeutic efficacy of 17-DMAG in colon cancer cells. Tumor Biology 2015; 36(6): 4367 doi: 10.1007/s13277-015-3076-0
|
| 7 |
Karl J. Okolotowicz, Mary Dwyer, Daniel Ryan, Jiongjia Cheng, Emily A. Cashman, Stephanie Moore, Mark Mercola, John R. Cashman. Novel tertiary sulfonamides as potent anti-cancer agents. Bioorganic & Medicinal Chemistry 2018; 26(15): 4441 doi: 10.1016/j.bmc.2018.07.042
|
| 8 |
Jeng-Wei Lu, Yi-Jung Ho, Shih-Ci Ciou, Zhiyuan Gong. Innovative Disease Model: Zebrafish as an In Vivo Platform for Intestinal Disorder and Tumors. Biomedicines 2017; 5(4): 58 doi: 10.3390/biomedicines5040058
|
| 9 |
Efrat Dotan, Steven J. Cohen, Alexander N. Starodub, Christopher H. Lieu, Wells A. Messersmith, Pamela S. Simpson, Michael J. Guarino, John L. Marshall, Richard M. Goldberg, J. Randolph Hecht, William A. Wegener, Robert M. Sharkey, Serengulam V. Govindan, David M. Goldenberg, Jordan D. Berlin. Phase I/II Trial of Labetuzumab Govitecan (Anti-CEACAM5/SN-38 Antibody-Drug Conjugate) in Patients With Refractory or Relapsing Metastatic Colorectal Cancer. Journal of Clinical Oncology 2017; 35(29): 3338 doi: 10.1200/JCO.2017.73.9011
|
| 10 |
Prachi Bajpai, Nilam Sanjib Banerjee, Dianne W. Moore, Hyung-Gyoon Kim, Farrukh Afaq, Carlo M. Contreras, Martin J. Heslin, Vishnu B. Reddy, Shajan Peter, Sooryanarayana Varambally, Sameer Al Diffalha, Upender Manne. Developing 3D Organoid Raft Cultures from Patient-Derived Xenografts as Rapid Models to Screen Efficacy of Experimental Therapeutics. International Journal of Molecular Sciences 2022; 23(22): 14392 doi: 10.3390/ijms232214392
|
| 11 |
Jiongjia Cheng, Mary Dwyer, Karl J. Okolotowicz, Mark Mercola, John R. Cashman. A Novel Inhibitor Targets Both Wnt Signaling and ATM/p53 in Colorectal Cancer. Cancer Research 2018; 78(17): 5072 doi: 10.1158/0008-5472.CAN-17-2642
|
| 12 |
Eva Romaní-Cubells, Samuel Martinez-Erro, Victoria Morales, Rafael van Grieken, Rafael A. García Muñoz, Raul Sanz. Mitoxantrone-Derivative Drug Structure-Directing Agent for the Synthesis of Magnetic Mesoporous Silica Nanoparticles for Breast Cancer Treatment. ACS Applied Nano Materials 2024; 7(11): 12376 doi: 10.1021/acsanm.4c00393
|
| 13 |
Rachel M. Lee, Kenneth Cardona, Maria C. Russell. Historical perspective: Two decades of progress in treating metastatic colorectal cancer. Journal of Surgical Oncology 2019; 119(5): 549 doi: 10.1002/jso.25431
|
| 14 |
Hidetaka Kawamura, Yusuke Ogawa, Hajime Yamazaki, Michitaka Honda, Koji Kono, Shinichi Konno, Shunichi Fukuhara, Yosuke Yamamoto. Impact of Primary Tumor Resection on Mortality in Patients with Stage IV Colorectal Cancer with Unresectable Metastases: A Multicenter Retrospective Cohort Study. World Journal of Surgery 2021; 45(10): 3230 doi: 10.1007/s00268-021-06233-x
|
| 15 |
Haneen Amawi, Noor A. Hussein, Charles R. Ashby, Rawan Alnafisah, Leticia M. Sanglard, Elangovan Manivannan, Chandrabose Karthikeyan, Piyush Trivedi, Kathryn M. Eisenmann, Robert W. Robey, Amit K. Tiwari. Bax/Tubulin/Epithelial-Mesenchymal Pathways Determine the Efficacy of Silybin Analog HM015k in Colorectal Cancer Cell Growth and Metastasis. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.00520
|
| 16 |
Shinya Ohno, Yirong Chen, Hiroyuki Sakamaki, Naoki Matsumaru, Katsura Tsukamoto. A population-based study of the humanistic burden among cancer patients in Japan. Journal of Medical Economics 2020; 23(5): 429 doi: 10.1080/13696998.2019.1707213
|
| 17 |
Changfu Qin, Yingmo Shen, Baoshan Wang, Xuefei Zhao, Yiting Liu, Shuo Yang, Jie Chen. An acellular tissue matrix-based drug carriers with dual chemo-agents for colon cancer growth suppression. Biomedicine & Pharmacotherapy 2019; 117: 109048 doi: 10.1016/j.biopha.2019.109048
|
| 18 |
Suk-young Lee, Sang Cheul Oh. Advances of Targeted Therapy in Treatment of Unresectable Metastatic Colorectal Cancer. BioMed Research International 2016; 2016: 1 doi: 10.1155/2016/7590245
|
| 19 |
Shinya Ohno, Yirong Chen, Hiroyuki Sakamaki, Naoki Matsumaru, Katsura Tsukamoto. Factors associated with humanistic burden and indirect cost among patients with cancer in Japan. Journal of Medical Economics 2020; 23(12): 1570 doi: 10.1080/13696998.2020.1839234
|
| 20 |
Zuzana Kozovska, Veronika Gabrisova, Lucia Kucerova. Colon cancer: Cancer stem cells markers, drug resistance and treatment. Biomedicine & Pharmacotherapy 2014; 68(8): 911 doi: 10.1016/j.biopha.2014.10.019
|
| 21 |
Lene H. Iversen, Anders Green, Peter Ingeholm, Kell Østerlind, Ismail Gögenur. Improved survival of colorectal cancer in Denmark during 2001–2012 – The efforts of several national initiatives. Acta Oncologica 2016; 55(sup2): 10 doi: 10.3109/0284186X.2015.1131331
|
| 22 |
Jae Hyun Kim, Seun Ja Park. Target Therapy in Unresectable or Metastatic Colorectal Cancer. The Korean Journal of Gastroenterology 2016; 68(6): 303 doi: 10.4166/kjg.2016.68.6.303
|
| 23 |
Curt Balch, Jayaram B. Ramapuram, Amit K. Tiwari. The Epigenomics of Embryonic Pathway Signaling in Colorectal Cancer. Frontiers in Pharmacology 2017; 8 doi: 10.3389/fphar.2017.00267
|